z-logo
open-access-imgOpen Access
Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia
Author(s) -
Norio Asou,
Eisaku Iwanaga,
Tomoko Nanri,
Hiroaki Mitsuya
Publication year - 2010
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2010.27656
Subject(s) - acute promyelocytic leukemia , imatinib mesylate , myeloid leukemia , medicine , myeloproliferative neoplasm , pdgfrb , imatinib , cancer research , retinoic acid , myeloid , targeted therapy , tretinoin , leukemia , oncology , pharmacology , immunology , bone marrow , biology , myelofibrosis , cancer , cell culture , biochemistry , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here